(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

CYTOSCRIBE

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

CYTOSCRIBE

ST13

US500000099045524

Class

42

Filing

99045524

Registration

8307608

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

21

Latest update

06/16/2026

Trademark type

Word

Nice classes

42

Filing date

02/18/2025

Registration date

06/16/2026

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

06/16/2026

Last transaction

06/16/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

10/22/2025

First use in commerce

10/22/2025

Drawing code

4

Owner type

03

Owner location

San Diego, CA, US

Examiner

LEE, SANG MIN

Law office

M20

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

BioLegend, Inc.

Representatives

Kevin A. Oliver Revvity, Inc.

Technical classification

Nice Classes

Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 42

Providing online non-downloadable computer software platforms for scientific research; Providing online non-downloadable computer software platforms for use in molecular biology; Providing online non-downloadable computer software platforms for use in biotechnology research; Providing online non-downloadable computer software platforms for cell cycle analysis; Providing online non-downloadable computer software platforms for gene expression profiling; Providing online non-downloadable computer software platforms for cell sorting; Providing online non-downloadable computer software platforms for protein expression; Providing online non-downloadable computer software platforms for importing and analyzing data; Providing online non-downloadable computer software platforms for database management; Providing online non-downloadable computer software platforms for organizing and managing experiments; Providing online non-downloadable computer software platforms for analysis of scientific data and information for use in analyzing cells and particles using reflective and fluorescent properties produced by a flow cytometer apparatus or device; Compiling data for research purposes in the field of medical science and medical consultancy

Publications

History of USPTO decisions and trademark events.

21 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

06/16/2026

R.PR

REGISTERED-PRINCIPAL REGISTER

06/16/2026

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

05/27/2026

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

05/27/2026

SUPC

STATEMENT OF USE PROCESSING COMPLETE

05/10/2026

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

05/09/2026

IUAF

USE AMENDMENT FILED

12/23/2025

EISU

TEAS STATEMENT OF USE RECEIVED

12/23/2025

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

10/28/2025

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

09/02/2025

PUBO

PUBLISHED FOR OPPOSITION

09/02/2025

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

08/27/2025

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

08/04/2025

XAEC

EXAMINER'S AMENDMENT ENTERED

08/04/2025

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

08/04/2025

GNEA

EXAMINERS AMENDMENT E-MAILED

08/04/2025

CNEA

EXAMINERS AMENDMENT -WRITTEN

08/04/2025

DOCK

ASSIGNED TO EXAMINER

07/24/2025

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

07/15/2025

MAFR

APPLICATION FILING RECEIPT MAILED

02/18/2025

NWAP

NEW APPLICATION ENTERED

02/18/2025

Continuous trademark protection

Get notified about every new filing that threatens CYTOSCRIBE or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.